drugset / Trial / NCT02978417
Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings
Phase 4
Completed
14 enrolled
Duke University
Alkermes, Inc. · collabFHR (Fellowship Health Resources, Inc.) · collabLaura and John Arnold Foundation · collabWake County Recovery Court · collab
RandomizedParallel-groupOpen-labelOther
Summary
In preparation for a large-scale randomized controlled trial (RCT) of Vivitrol® effectiveness in drug courts, investigators propose a feasibility study in the Wake County, North Carolina drug court, where an estimated 50% of clients are opioid dependent. Aim 1: Pilot RCT. Pilot-test the delivery of Vivitrol® treatment for 10-20 interested and eligible clients of the Wake County Drug Court.
Timeline
- Start
- 2017-09-21
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naltrexone | Small molecule | 380 mg | Intramuscular |